Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001491877-11-000011
Filing Date
2011-05-27
Accepted
2011-05-27 15:43:57
Documents
1
Period of Report
2011-05-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3818
  Complete submission text file 0001491877-11-000011.txt   5588
Mailing Address 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12276 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address
COX GEOFFREY F (Reporting) CIK: 0001021014 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 11878168
SIC: 2836 Biological Products, (No Diagnostic Substances)